572 related articles for article (PubMed ID: 18006253)
1. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
Siedek EM; Schmidt H; Sture GH; Raue R
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
[TBL] [Abstract][Full Text] [Related]
3. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
4. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
[TBL] [Abstract][Full Text] [Related]
6. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant?
Larson LJ; Schultz RD
Vet Ther; 2008; 9(2):94-101. PubMed ID: 18597247
[TBL] [Abstract][Full Text] [Related]
7. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
Larson LJ; Schultz RD
Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
Litster A; Nichols J; Volpe A
Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of dogs with Duramune DAPPi+LC protects against pathogenic canine parvovirus type 2c challenge.
Wilson S; Stirling C; Borowski S; Thomas A; King V; Salt J
Vet Rec; 2013 Jun; 172(25):662. PubMed ID: 23748583
[TBL] [Abstract][Full Text] [Related]
10. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
Larson LJ; Schultz RD
Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
[TBL] [Abstract][Full Text] [Related]
11. Response of puppies to canine-origin parvovirus vaccines.
Carmichael LE; Pollock RV; Joubert JC
Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
[TBL] [Abstract][Full Text] [Related]
13. Thoughts on vaccination protocols.
Petzel B
J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
[No Abstract] [Full Text] [Related]
14. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
[TBL] [Abstract][Full Text] [Related]
15. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c.
Decaro N; Desario C; Elia G; Martella V; Mari V; Lavazza A; Nardi M; Buonavoglia C
New Microbiol; 2008 Jan; 31(1):125-30. PubMed ID: 18437851
[TBL] [Abstract][Full Text] [Related]
16. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
[TBL] [Abstract][Full Text] [Related]
17. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
[TBL] [Abstract][Full Text] [Related]
18. Thoughts on vaccination protocols.
McLaughlin MA
J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
[No Abstract] [Full Text] [Related]
19. Antibody levels and protection to canine parvovirus type 2.
Elia G; Cavalli A; Cirone F; Lorusso E; Camero M; Buonavoglia D; Tempesta M
J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):320-2. PubMed ID: 16316392
[TBL] [Abstract][Full Text] [Related]
20. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
